Psychosis News and Research

RSS

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''

Smokers at greater risk of schizophrenia and psychotic disorders

A team of researchers from University of Queensland have found that tobacco use is associated with an increased risk of psychotic disorders including schizophrenia.

21 Nov 2018

Noise pollution in hospital impact quality and safety of healthcare

In an editorial published today in the BMJ, researchers from King's College London and the University of the Arts London argue that it is a worsening problem, with levels regularly exceeding international recommendations.

19 Nov 2018

EMA recommends first all-oral treatment to tackle deadly sleeping sickness

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness.

16 Nov 2018

Brain activity pattern linked with development of schizophrenia

Schizophrenia, a brain disorder that produces hallucinations, delusions, and cognitive impairments, usually strikes during adolescence or young adulthood. While some signs can suggest that a person is at high risk for developing the disorder, there is no way to definitively diagnose it until the first psychotic episode occurs.

8 Nov 2018

New reviews analyze symptom stability over the course of psychiatric disorders

In patients with psychiatric disorders, stability of symptoms has important implications for diagnosis, prognosis, and treatment.

31 Oct 2018

Researchers find key differences in brains of males and females with schizophrenia

Researchers from the Icahn School of Medicine at Mount Sinai have found clear disparities in the way males and females--both those with schizophrenia and those who are healthy--discern the mental states of others.

30 Oct 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

Multi-national database can help researchers address questions about bipolar disorder throughout adult lifespan

Not much is known about how bipolar disorder (BD) affects people throughout their lives. Do women and men differ in the severity of their symptoms?

23 Oct 2018

Scientists receive Young Investigator Grants from Brain & Behavior Research Foundation

The Brain & Behavior Research Foundation today announced the awarding of its Young Investigator Grants valued at more than $13.8 million to 200 of the world's most promising young scientists.

5 Oct 2018

New drug to treat Parkinson's disease psychosis do not pose greater risk of death

In the wake of media and public reports about increased mortality linked to a new drug for treating Parkinson's disease psychosis -- a symptom of the progressive nervous system disorder in which patients experience hallucinations and delusions -- researchers at University of California San Diego School of Medicine conducted a retrospective study of qualifying patients in the UC San Diego Health system, concluding that the new drug, pimavanserin, did not pose a statistically significant greater risk of death.

27 Sep 2018

Machine learning may be useful tool to predict outcomes for people at risk of psychosis, depression

Machine learning, also known as artificial intelligence, could be a useful tool for predicting how well people at high risk of psychosis or with recent onset depression will function socially in the future, an international research study has found.

26 Sep 2018

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

24 Sep 2018

Old letters provide insight into Spanish flu pandemic horror

An archive of letters written by those who survived the Spanish flu pandemic at the start of the last century shows what it was actually like to live during that time. The Spanish flu pandemic killed over 250,000 people in Britain alone and worldwide it wiped out a population of over 100 million.

23 Sep 2018

Breakthrough shows immune cells may play a role in schizophrenia

A type of immune cell called the “macrophages” are known to be one of the first soldiers of the body that can fight off infections and plays a role in maintaining immunity and in inflammation. According to latest research in schizophrenia, these macrophages can become altered and may cause changes in the brain leading to changes in the brain similar to schizophrenia.

14 Sep 2018

Study reaffirms success of conditional release programs for criminally insane individuals

After being found not guilty by reason of insanity, it's not typically a crime - rather declining mental health or breaking rules of conditional release like not drinking alcohol - that puts people back in a psychiatric hospital or even jail, researchers say.

6 Sep 2018

Dopamine receptor study opens door to targeted treatments for neuropsychiatric disorders

New work from researchers at Columbia University Vagelos College of Physicians and Surgeons sheds light on how dopamine receptors signal within cells, opening the door for more targeted--and more tolerable--therapeutics to treat an array of neuropsychiatric disorders.

4 Sep 2018

Component of cannabis could help in psychosis

Researchers from King’s College London have now found how the chemical cannabidiol or CBD from cannabis can reduce the abnormal brain activity in patients who are at risk of psychosis. The study was published in the latest issue of the journal JAMA Psychiatry.

30 Aug 2018

Cannabis use and mental illness link found

A large new study has found that people with mental ailments such as schizophrenia are more genetically inclined to use cannabis.

29 Aug 2018

Psychologist to assess how the brain maintains precise short-term and long-term memories

A person's general intelligence and ability to understand language are reliant on the brain's ability to maintain precise information acquired over a short period of time.

17 Aug 2018

Long-term cannabinoid exposure impairs memory, study shows

A new study led by Ana Sebastião, group leader at Instituto de Medicina Molecular João Lobo Antunes and Professor of Faculdade de Medicina of Universidade de Lisboa and her team in collaboration with researchers from the University of Lancaster, shows that the long-term use of either cannabis or cannabis-based drugs impairs memory.

13 Aug 2018